484 related articles for article (PubMed ID: 17542294)
1. Is Helicobacter pylori eradication indicated in cirrhotic patients with peptic ulcer disease?
Villalan R; Maroju NK; Kate V; Ananthakrishnan N
Trop Gastroenterol; 2006; 27(4):166-8. PubMed ID: 17542294
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
[TBL] [Abstract][Full Text] [Related]
3. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
4. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori infection in dyspeptic cirrhotic patients.
Zullo A; Rinaldi V; Meddi P; Folino S; Lauria V; Diana F; Winn S; Attili AF
Hepatogastroenterology; 1999; 46(25):395-400. PubMed ID: 10228829
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori density and cagA status in cirrhotic patients: a case-control study.
Zullo A; Sanchez-Mete L; Hassan C; Diana F; Festuccia F; Attili AF; Morini S
J Gastroenterol Hepatol; 2004 Oct; 19(10):1174-8. PubMed ID: 15377296
[TBL] [Abstract][Full Text] [Related]
7. A comparative study on Helicobacter pylori infection in peptic ulcer disease patients with or without previous eradication therapy.
Chen LW; Chien RN; Fang KM; Yen CL; Chang JJ; Lee TS; Liu CJ; Chang LC
Hepatogastroenterology; 2007 Dec; 54(80):2209-11. PubMed ID: 18265634
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and role of Helicobacter pylori infection in some gastroduodenal and hepatic complications in cirrhotic patients].
Săndulache L; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):890-5. PubMed ID: 20209758
[TBL] [Abstract][Full Text] [Related]
9. Rapid urease tests lack sensitivity in Helicobacter pylori diagnosis when peptic ulcer disease presents with bleeding.
Lee JM; Breslin NP; Fallon C; O'Morain CA
Am J Gastroenterol; 2000 May; 95(5):1166-70. PubMed ID: 10811322
[TBL] [Abstract][Full Text] [Related]
10. Eradicating Helicobacter pylori in peptic ulcer disease reduces medical costs in the community.
Sone Y; Kumada T; Toyoda H; Yokoyama M; Kato M; Asaka M
Helicobacter; 2008 Oct; 13(5):346-51. PubMed ID: 19250509
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
12. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
13. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease.
Saxena A; Nath Prasad K; Chand Ghoshal U; Krishnani N; Roshan Bhagat M; Husain N
Scand J Gastroenterol; 2008; 43(6):669-74. PubMed ID: 18569983
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial.
Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF
Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Helicobacter pylori "test and treat" for patients with typical reflux symptoms in a population with a high prevalence of H. pylori infection: a Markov model analysis.
You JH; Wong PL; Wu JC
Scand J Gastroenterol; 2006 Jan; 41(1):21-9. PubMed ID: 16373272
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital.
Vu C; Ng YY
Singapore Med J; 2000 Oct; 41(10):478-81. PubMed ID: 11281437
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT; Forne M; de Argila CM; Feu F; Arenas J; de la Vega J; Garrigues V; Mora F; Castro M; Bujanda L; Cosme A; Castiella A; Gisbert JP; Hervas A; Lanas A
Helicobacter; 2004 Jun; 9(3):249-54. PubMed ID: 15165261
[TBL] [Abstract][Full Text] [Related]
19. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of peptic ulcer disease in cirrhotic patients: role of Helicobacter pylori infection.
Calvet X; Navarro M; Gil M; Lafont A; Sanfeliu I; Brullet E; Campo R; Dalmau B; Rivero E; Mas P
Am J Gastroenterol; 1998 Dec; 93(12):2501-7. PubMed ID: 9860415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]